Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms

NCT02823184 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02823184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02823184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
April 27, 2017
Completion date
April 27, 2019
Enrollment
148 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, polycythemia vera